News

August 27, 2018August 27, 2018

First Hemophilia B Patient Treated with AMT-061 in Phase 2b Trial

News

uniQure has treated the first patient in a Phase 2b dose-confirmation study of its investigational gene therapy, AMT-061, for people with severe and moderately severe hemophilia B. The trial ... Read more

August 22, 2018August 22, 2018

Irish Medical University and Bayer Partner to Advance Treatments for Hemophilia

News

The Royal College of Surgeons in Ireland (RCSI) and Bayer will collaborate to develop improved treatments for patients with severe hemophilia. The research collaboration will focus on personalized treatments ... Read more

August 20, 2018August 20, 2018

Phase 2/3 Clinical Trial of MarzAA Shows Promise in Hemophilia Treatment

News

Catalyst Biosciences announced positive interim results from a Phase 2/3 clinical trial (NCT03407651) of the Factor VIIa variant marzeptacog alfa (activated) (MarzAA) in the preventative treatment of patients with ... Read more

August 13, 2018August 13, 2018

Hemlibra Approved in Canada to Treat Hemophilia A Patients with Factor VIII Inhibitors

News

Health Canada has approved Hemlibra (emicizumab) as a treatment to prevent or reduce bleeding in Hemophilia A patients in Canada who have factor VIII inhibitors. Hemlibra is an antibody ... Read more

August 8, 2018August 8, 2018

Multiple Factors Contribute to Development of FVIII Inhibitors in Hemophilia, Review Finds

News

Several genetic and environmental factors can play a role in the development of inhibitors against treatment with factor VIII in hemophilia A patients, according to a review study. The ... Read more

August 6, 2018August 6, 2018

Employment Status, Pain, Low Physical Activity Linked to Anxiety, Depression in Hemophilia Patients

News

A study that examined the role of emotional distress in the lives of hemophilia patients found that a patient’s employment status, pain interference levels, perception of the detrimental consequences ... Read more

July 31, 2018July 31, 2018

Hemophilia Federation of America Gathering Memorabilia to Mark 25 Years of Service

News

The Hemophilia Federation of America (HFA) is seeking a variety of historical artifacts and records to add to its archival project in honor of its upcoming 25th year of helping ... Read more

July 30, 2018August 10, 2018

Gene Therapy Wins Over Prophylaxis in Cost-Benefit Analysis as Long-term Treatment for Severe Hemophilia A

News

A gene therapy that can treat patients with severe hemophilia A is likely to be more cost-effective over the long term than reliance on prophylactic (preventive) therapy using factor ... Read more

July 27, 2018July 27, 2018

New Kit Demonstrates Clinical Validity as Measure of FVIII Inhibitors in Hemophilia A

News

Precision BioLogic revealed promising data on a new kit for the measurement of FVIII inhibitors (factor VIII) in patients with hemophilia A. The results were presented at the International ... Read more

July 25, 2018July 25, 2018

The Assistance Fund Offers New Program to Help Hemophilia Patients with Medical Expenses

News

Hemophilia patients may now benefit from financial assistance for out-of-pocket expenses, health insurance premiums, and incidental medical costs following the launch of a new program from The Assistance Fund (TAF). ... Read more

Pin It on Pinterest